Highly active antiretroviral therapy: cardiovascular risk needs to be assessed before starting treatment.
Saved in:
| Title: | Highly active antiretroviral therapy: cardiovascular risk needs to be assessed before starting treatment. |
|---|---|
| Authors: | Moerman F (AUTHOR), Van Gompel A (AUTHOR), Nimmegeers J (AUTHOR), Moerman J (AUTHOR) |
| Source: | BMJ: British Medical Journal (International Edition). 6/11/2005, Vol. 330 Issue 7504, p1341-1342. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598146 |
|---|---|
| DOI: | 10.1136/bmj.330.7504.1341 |
